KEAP1 and non-small cell lung carcinoma: Solis et al. further explored nuclear Nrf2 and cytoplasm Keap1 immunohistochemical expression in 304 NSCLC patients and reported that nuclear Nrf2 expression associated with worse progress-free survival in squamous cell cancer patients who underwent adjuvant treatment [35].